Blood-brain barrier properties of human immunodeficiency virus antiretrovirals.
Yazdanian
M
M
Department of Pharmaceutics, Boehringer Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, P.O. Box 368, Ridgefield, Connecticut 06877, USA. myazdani@rdg.boehringer-ingelheim.com
D000818:Animals; D019380:Anti-HIV Agents / Q000493:pharmacokinetics*; D001812:Blood-Brain Barrier / Q000187:drug effects / Q000502:physiology*; D015658:HIV Infections / Q000378:metabolism; D006801:Humans
D019380:Anti-HIV Agents